Page 10 - ESGO - Vulvar cancer - Complete report_fxd2
P. 10
5.7 Chemoradiation
C Definitive chemoradiation with radiation dose escalation is the treatment of choice in patients with
unresectable disease.
C In advanced stage disease neoadjuvant chemoradiation should be considered in order to avoid
exenterative surgery.
C Radiosensitising chemotherapy, preferably with weekly cisplatin, is recommended.
5.8 Systemic treatment
D Data in vulvar cancer are insufficient to recommend a preferred schedule in a palliative setting.
5.9 Treatment of recurrent disease
Treatment of vulvar recurrence
Radical local excision is recommended.
For vulvar recurrence with a depth of invasion > 1 mm and previous sentinel lymph node removal
only, inguinofemoral lymphadenectomy should be performed.
The indications for postoperative radiotherapy are comparable to those for the treatment of primary
disease.
Treatment of groin recurrence
Restaging by CT or PET -CT of the thorax/abdomen/pelvis is recommended.
Preferred treatment is radical excision when possible, followed by postoperative radiation in
radiotherapy naïve patients.
Based on evidence from other squamous cell cancers such as cervical and anal cancer, the addition of
radiosensitising chemotherapy to postoperative radiotherapy should be considered.
Definitive chemoradiation when surgical treatment is not possible.
Treatment of distant metastases
Systemic palliative therapy may be considered in individual patients see systemic treatment).
VULVAR CANCER - GUIDELINES
10